Trials / Completed
CompletedNCT06996769
Constraint-Induced Movement Therapy After Stroke
Constrain Induced Therapy to Improve Motor Function and Body Balance in Patients With Stroke
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hanan Hosny M Battesha · Academic / Other
- Sex
- All
- Age
- 50 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Constraint-induced movement therapy (CIMT) is a neurological rehabilitation treatment designed to improve upper and lower extremities motor functions after stroke. The basis of CIMT is improving the function of the affected limb after a stroke by restricting the use of the healthy limb and forcing the use of the affected side. The core strategy of CIMT is the application of movement techniques, behavioral techniques and restriction methods to increase the frequency of use of the affected limb in stroke patients, improve the quality of movement of the affected limb in real-life scenarios, prevent or correct the learned non-use of the affected limb, and promote the recovery of motor function in the affected limb. This method induces the use of the affected limb, corrects or reverses habitual disuse and neglect of the affected limb, and provides structural and functional training and repeated practice opportunities for the affected limb.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | constraint induced therapy | Constraint induced movement therapy (CIMT) is a treatment approach that can be used with patients who have had a CVA. In order to be eligible for the therapy, the clients must have at least 10 degrees of active wrist and finger extension. During this treatment the unaffected limb is restrained (usually with a sling or a mitt) for 90% of their waking hours. This treatment forces the client to use the affected limb throughout their daily tasks in order to combat learned non-use of the affected limb. |
| OTHER | Conventional therapy for stroke patient | general exercises |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-07-15
- Completion
- 2025-08-20
- First posted
- 2025-05-30
- Last updated
- 2025-08-22
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT06996769. Inclusion in this directory is not an endorsement.